Delivery Order SPE2DR25D1202-SPE2DR26F75TF
Award Date 3/9/26
Potential Completion Date 3/10/26
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 9, 2026, for risperidone 0.25 mg tablets (60-count), with a ceiling value of $3,223.48. Place of performance is Conshohocken, PA 19428. The order has an ultimate completion date of March 10, 2026 and is firm fixed price. The delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which provides pharmaceutical and medical...
- The Defense Logistics Agency issued a $5,161.10 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for RISPERDAL 2 mg tablets (60-count units). The order is issued under an Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA....
- The Defense Logistics Agency issued a $5,506.51 delivery order to AmerisourceBergen Drug Corp on February 12, 2026, for Risperidone 0.5 mg tablets (500 count). The order is issued under the parent DLA Troop Support Medical IDC (SPE2DX), valued at $999,999,999.00 through December 2026, a comprehensive global pharmaceutical supply vehicle enabling delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a $2,382.60 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Risperdal 3 mg tablets (60-count supply). Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 13, 2026. The delivery order was issued under the parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which supplies...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for Risperidone 0.25 mg tablets (500 count) with a ceiling value of $1,028.17. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This vehicle serves as a global pharmaceutical support contract enabling supply of a broad range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Risperdal 0.5 mg tablets (60-count), with a ceiling value of $2,188.80. Place of performance is Conshohocken, PA. The ultimate completion date is February 18, 2026. This firm fixed-price delivery order was issued without a set-aside under a parent Indefinite Delivery Contract with the DLA Troop Support Medical that supports pharmaceutical supply to military healthcare programs globally.
- The Defense Logistics Agency issued a $1,311.45 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Risperidone 2 mg tablets (60-count units) under firm fixed-price terms. The order ceiling value matches the award value at $1,311.45, with an ultimate completion date of March 11, 2026. Place of performance is Conshohocken, PA. The delivery order was issued under no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a major pharmaceutical...
- The Defense Logistics Agency issued a $1,195.78 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Risperdal 0.5 mg tablets (60-count). Ultimate completion date is February 11, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was issued under no set-aside. The source does not identify the parent IDC vehicle name explicitly; the awardee holds a significant IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,915.37 to AmerisourceBergen Drug Corp for the supply of Risperidone 3 mg tablets (60-count units). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Risperidone 3 mg orally disintegrating tablets in unit dose packages of 28 units, with a ceiling value of $1,142.97. This non-competitive delivery order, issued on December 15, 2025, with completion scheduled for December 16, 2025, utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting federal medical supply needs. The order will be fulfilled from the vendor's facility...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F75TFDelivery Order
The Defense Logistics Agency issued a $1,963.18 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for risperidone 3 mg tablets (60-count), with an ultimate completion date of March 10, 2026. The order is issued under a firm fixed-price structure. Place of performance is Conshohocken, PA. The parent vehicle is an Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999 through December 2026, which serves as the global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies across military healthcare programs worldwide. No set-aside was used for this order.
Generated 6/7/26, 9:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/8/26 |